Aicuris Anti Infect Drug Patent Portfolio
Aicuris Anti Infect owns 1 orange book drug protected by 5 US patents Given below is the list of Aicuris Anti Infect's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9119786 | Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations | 26 Sep, 2032 | Active |
| US9340535 | N-[5-(Aminosulfony1)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mesylate Monohydrate | 26 Sep, 2032 | Active |
| US9889124 | Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations | 26 Sep, 2032 | Active |
| USRE49697 | 26 Sep, 2032 | Active | |
| US8784887 | Pharmaceutical Preparation Of N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide | 18 Jul, 2029 | Active |
Aicuris Anti Infect's Family Patents
Aicuris Anti Infect Drug List
Given below is the complete list of Aicuris Anti Infect's drugs and the patents protecting them.
1. Hovilpri
Hovilpri is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9119786 | Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations |
26 Sep, 2032
(5 years from now)
| Active |
| US9340535 | N-[5-(Aminosulfony1)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mesylate Monohydrate |
26 Sep, 2032
(5 years from now)
| Active |
| US9889124 | Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations |
26 Sep, 2032
(5 years from now)
| Active |
| USRE49697 |
26 Sep, 2032
(5 years from now)
| Active | |
| US8784887 | Pharmaceutical Preparation Of N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide |
18 Jul, 2029
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hovilpri's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List